HOMCY CHARLES J 4
4 · BridgeBio Pharma, Inc. · Filed Aug 12, 2025
Insider Transaction Report
Form 4
HOMCY CHARLES J
Director
Transactions
- Sale
Common Stock
2025-08-08$46.64/sh−58,338$2,720,849→ 966,674 total - Sale
Common Stock
2025-08-08$45.87/sh−191,662$8,791,593→ 1,025,012 total - Sale
Common Stock
2025-08-11$48.00/sh−50,000$2,400,000→ 916,674 total
Footnotes (3)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on May 8, 2025.
- [F2]Represents the weighted average sale price of the shares sold from $45.395 to $46.38 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.
- [F3]Represents the weighted average sale price of the shares sold from $46.40 to $46.84 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.